{"database": "openregs", "table": "documents", "rows": [["FDA-2015-P-2820-0056", "FDA", "FDA-2015-P-2820", "Status Inquiry re Requests that the FDA modify existing regulations in Title 21 of the Code of Federal Regulations (CFR) that govern requirements for investigational new drug (IND) applications, investigational device exemptions (IDE), and new drug applications (NDAs).", "Supporting & Related Material", "Background Material", "2016-03-09T05:00:00Z", 2016, 3, null, null, "2016-03-09T17:21:15Z", null, 0, 0, "0900006481eb5c8b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-P-2820-0056"], "units": {}, "query_ms": 0.46129501424729824, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}